Atalanta Sosnoff Capital, LLC Eli Lilly & CO Transaction History

Atalanta Sosnoff Capital, LLC

$4.33 Billion
Q1 2024

A detailed history of Atalanta Sosnoff Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Atalanta Sosnoff Capital, LLC holds 161,114 shares of LLY stock, worth $130 Million. This represents 2.9% of its overall portfolio holdings.

Number of Shares

161,114

Previous 167,190 3.63%

Holding current value

$130 Million

Previous $97.5 Million 28.61%

% of portfolio

2.9%

Previous 2.51%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $3.6 Million - $4.81 Million	-6,076 Reduced 3.63%	161,114 $125 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $2.87 Million - $3.39 Million	-5,468 Reduced 3.17%	167,190 $97.5 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $21.4 Million - $29.5 Million	-49,218 Reduced 22.18%	172,658 $92.7 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $2.13 Million - $2.84 Million	-6,063 Reduced 2.66%	221,876 $104 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $8.02 Million - $9.42 Million	25,827 Added 12.78%	227,939 $78.3 Million

Q4 2022 May 22, 2023	SELL	$321.55 - $374.67 $8.3 Million - $9.68 Million	-25,827 Reduced 11.33%	202,112 $73.9 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $8.59 Million - $10 Million	-26,719 Reduced 11.68%	202,112 $73.9 Million
Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $1.05 Million - $1.19 Million	-3,534 Reduced 1.52%	228,831 $74 Million
Q2 2022 Jul 14, 2022	BUY	$278.73 - $327.27 $21.5 Million - $25.3 Million	77,298 Added 49.85%	232,365 $75.3 Million
Q1 2022 Apr 11, 2022	BUY	$234.69 - $291.66 $1.43 Million - $1.78 Million	6,099 Added 4.09%	155,067 $44.4 Million
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $57,561 - $71,434	256 Added 0.17%	148,968 $41.1 Million
Q3 2021 Oct 14, 2021	BUY	$221.6 - $272.71 $317,109 - $390,248	1,431 Added 0.97%	148,712 $34.4 Million
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $259,811 - $336,064	-1,439 Reduced 0.97%	147,281 $33.8 Million
Q1 2021 Apr 20, 2021	SELL	$164.32 - $212.72 $39.2 Million - $50.8 Million	-238,584 Reduced 61.6%	148,720 $27.8 Million
Q4 2020 Jan 14, 2021	SELL	$130.46 - $172.63 $3.09 Million - $4.08 Million	-23,656 Reduced 5.76%	387,304 $65.4 Million
Q3 2020 Oct 14, 2020	SELL	$146.22 - $169.13 $1.24 Million - $1.44 Million	-8,500 Reduced 2.03%	410,960 $60.8 Million
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $773,364 - $930,736	-5,669 Reduced 1.33%	419,460 $68.9 Million
Q1 2020 Apr 16, 2020	BUY	$119.05 - $147.35 $15 Million - $18.6 Million	126,054 Added 42.15%	425,129 $59 Million
Q4 2019 Jan 23, 2020	SELL	$106.92 - $132.43 $306,860 - $380,074	-2,870 Reduced 0.95%	299,075 $39.3 Million
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $24.7 Million - $26.9 Million	-231,159 Reduced 43.36%	301,945 $33.8 Million
Q2 2019 Jul 15, 2019	SELL	$110.79 - $129.32 $1.86 Million - $2.18 Million	-16,821 Reduced 3.06%	533,104 $59.1 Million
Q1 2019 Apr 09, 2019	SELL	$111.31 - $131.02 $3.1 Million - $3.65 Million	-27,860 Reduced 4.82%	549,925 $71.4 Million
Q4 2018 Jan 09, 2019	BUY	$105.9 - $118.64 $23.2 Million - $26 Million	219,347 Added 61.2%	577,785 $66.9 Million
Q3 2018 Oct 10, 2018	BUY	$85.86 - $107.31 $30.8 Million - $38.5 Million	358,438 New	358,438 $38.5 Million
Q2 2018 Jul 11, 2018	SELL	$75.7 - $86.88 $1.8 Million - $2.06 Million	-23,764 Closed	0 $0
Q1 2018 Apr 06, 2018	SELL	$74.21 - $87.6 $9,350 - $11,037	-126 Reduced 0.53%	23,764 $1.84 Million
Q4 2017 Jan 09, 2018	SELL	$81.94 - $87.89 $25,729 - $27,597	-314 Reduced 1.3%	23,890 $2.02 Million
Q3 2017 Oct 10, 2017	BUY	$77.07 - $85.54 $1.87 Million - $2.07 Million	24,204	24,204 $2.07 Million

Others Institutions Holding LLY

# of Institutions

3,774

Shares Held

737M

Call Options Held

7.09M

Put Options Held

7.22M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $768B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atalanta Sosnoff Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atalanta Sosnoff Capital, LLC with notifications on news.

Account

Atalanta Sosnoff Capital, LLC Eli Lilly & CO Transaction History